Advanced search
Publication Cover
Therapeutic Delivery Volume 3, 2012 - Issue 5
Submit an article Journal homepage
383
Views
0
CrossRef citations to date
0
Altmetric
Review

Improvement of the Bitter Taste of Drugs By Complexation With Cyclodextrins: applications, Evaluations and Mechanisms

Hidetoshi Arimaa Graduate School of Pharmaceutical Sciences Kumamoto University5–1 Oe-honmachiKumamoto862–0973Japan
,
Taishi Higashib Graduate School of Pharmaceutical Sciences Kumamoto University5–1 Oe-honmachiKumamoto862–[email protected]
&
Keiichi Motoyamab Graduate School of Pharmaceutical Sciences Kumamoto University5–1 Oe-honmachiKumamoto862–[email protected]
Pages 633-644 | Published online: 17 May 2012

References

  • Chandrashekar J , HoonMA, RybaNJ, ZukerCS. The receptors and cells for mammalian taste. Nature444(7117), 288–294 (2006).
  • Chen X , GabittoM, PengY, RybaNJ, ZukerCS. A gustotopic map of taste qualities in the mammalian brain. Science333(6047), 1262–1266 (2011).
  • Adler E , HoonMA, MuellerKL, ChandrashekarJ, RybaNJ, ZukerCS. A novel family of mammalian taste receptors. Cell100(6), 693–702 (2000).
  • Chandrashekar J , MuellerKL, HoonMAet al. T2Rs function as bitter taste receptors. Cell 100(6), 703–711 (2000).
  • Huang AL , ChenX, HoonMAet al. The cells and logic for mammalian sour taste detection. Nature 442(7105), 934–938 (2006).
  • Ishimaru Y , InadaH, KubotaM, ZhuangH, TominagaM, MatsunamiH. Transient receptor potential family members PKD1L3 and PKD2L1 form a candidate sour taste receptor. Proc. Natl Acad. Sci. USA103(33), 12569–12574 (2006).
  • Li X , StaszewskiL, XuH, DurickK, ZollerM, AdlerE. Human receptors for sweet and umami taste. Proc. Natl Acad. Sci USA99(7), 4692–4696 (2002).
  • Matsunami H , MontmayeurJP, BuckLB. A family of candidate taste receptors in human and mouse. Nature404(6778), 601–604 (2000).
  • Mueller KL , HoonMA, ErlenbachI, ChandrashekarJ, ZukerCS, RybaNJ. The receptors and coding logic for bitter taste. Nature434(7030), 225–229 (2005).
  • Nelson G , ChandrashekarJ, HoonMAet al. An amino-acid taste receptor. Nature 416(6877), 199–202 (2002).
  • Nelson G , HoonMA, ChandrashekarJ, ZhangY, RybaNJ, ZukerCS. Mammalian sweet taste receptors. Cell106(3), 381–390 (2001).
  • Zhao GQ , ZhangY, HoonMAet al. The receptors for mammalian sweet and umami taste. Cell 115(3), 255–266 (2003).
  • Nunn T , WilliamsJ. Formulation of medicines for children. Br. J. Clin. Pharmacol.59(6), 674–676 (2005).
  • Sohi H , SultanaY, KharRK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev. Ind. Pharm.30(5), 429–448 (2004).
  • Shammari SA , KhojaT, YamaniMJ. Compliance with short-term antibiotic therapy among patients attending primary health centres in Riyadh, Saudi Arabia. J. R. Soc. Health115(4), 231–234 (1995).
  • Dhoka MV , NimbalkarUA, PandeA. Preparation of cefpodoxime proxetil-polymeric microspheres by the emulsion solvent diffusion method for taste masking. Int. J. Chem. Tech. Res.3(1), 411–419 (2011).
  • Ayenew Z , PuriV, KumarL, BansalAK. Trends in pharmaceutical taste masking technologies: a patent review. Recent Pat. Drug Deliv. Formul.3(1), 26–39 (2009).
  • Behzadi SS , ToegelS, ViernsteinH. Innovations in coating technology. Recent Pat. Drug Deliv. Formul.2(3), 209–230 (2008).
  • Douroumis D . Practical approaches of taste masking technologies in oral solid forms. Expert Opin. Drug Deliv.4(4), 417–426 (2007).
  • Douroumis D . Orally disintegrating dosage forms and taste-masking technologies; 2010. Expert Opin. Drug Deliv.8(5), 665–675 (2011).
  • Gryczke A , SchminkeS, ManiruzzamanM, BeckJ, DouroumisD. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion. Colloids Surf. B Biointerfaces86(2), 275–284 (2011).
  • Hamashita T , MatsuzakiM, OnoTet al. Granulation of core particles suitable for film coating by agitation fluidized bed II. A proposal of a rapid dissolution test for evaluation of bitter taste of ibuprofen. Chem. Pharm. Bull. (Tokyo) 56(7), 883–887 (2008).
  • Hamashita T , NakagawaY, AketoT, WatanoS. Granulation of core particles suitable for film coating by agitation fluidized bed I. Optimum formulation for core particles and development of a novel friability test method. Chem. Pharm. Bull. (Tokyo)55(8), 1169–1174 (2007).
  • Yoshida T , TasakiH, MaedaA, KatsumaM, SakoK, UchidaT. Optimization of salting-out taste-masking system for micro-beads containing drugs with high solubility. Chem. Pharm. Bull. (Tokyo)56(11), 1579–1584 (2008).
  • Yoshida T , TasakiH, MaedaA, KatsumaM, SakoK, UchidaT. Salting-out taste-masking system generates lag time with subsequent immediate release. Int. J. Pharm.365(1–2), 81–88 (2009).
  • Yoshida T , TasakiH, MaedaA, KatsumaM, SakoK, UchidaT. Mechanism of controlled drug release from a salting-out taste-masking system. J. Control. Release131(1), 47–53 (2008).
  • Sikandar MK , MakviyaR, SharmaPK. Taste masking: an important pharmaceutical technology for the improvement of organoleptic property of pharmaceutical active agents. Eur. J. Biol. Sci.3(3), 67–71 (2011).
  • Albers E , MullerBW. Cyclodextrin derivatives in pharmaceutics. Crit. Rev. Ther. Drug Carrier Syst.12(4), 311–337 (1995).
  • Brewster ME , LoftssonT. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev.59(7), 645–666 (2007).
  • Challa R , AhujaA, AliJ, KharRK. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech6(2), E329–E357 (2005).
  • Davis ME , BrewsterME. Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov.3(12), 1023–1035 (2004).
  • Li J , LohXJ. Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery. Adv. Drug Deliv. Rev.60(9), 1000–1017 (2008).
  • Loftsson T , BrewsterME. Pharmaceutical applications of cyclodextrins: basic science and product development. J. Pharm. Pharmacol.62(11), 1607–1621 (2010).
  • Uekama K , HirayamaF, IrieT. Cyclodextrin drug carrier systems. Chem. Rev.98(5), 2045–2076 (1998).
  • Uekama K , OtagiriM. Cyclodextrins in drug carrier systems. Crit. Rev. Ther. Drug Carrier Syst.3(1), 1–40 (1987).
  • Debouzy JC , FauvelleF, CrouzySet al. Mechanism of α-cyclodextrin induced hemolysis. A study of the factors controlling the association with serine-, ethanolamine-, and choline-phospholipids. J. Pharm. Sci. 87(1), 59–66 (1998).
  • Fauvelle F , DebouzyJC, CrouzyS, GoschlM, ChapronY. Mechanism of α-cyclodextrin-induced hemolysis. The two-step extraction of phosphatidylinositol from the membrane. J. Pharm. Sci.86(8), 935–943 (1997).
  • Irie T , OtagiriM, SunadaMet al. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. J. Pharmacobiodyn. 5(9), 741–744 (1982).
  • Ohtani Y , IrieT, UekamaK, FukunagaK, PithaJ. Differential effects of α-, β- and γ-cyclodextrins on human erythrocytes. Eur. J. Biochem.186(1–2), 17–22 (1989).
  • Irie T , UekamaK. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci.86(2), 147–162 (1997).
  • Loftsson T , JarhoP, MassonM, JarvinenT. Cyclodextrins in drug delivery. Expert Opin. Drug Deliv.2(2), 335–351 (2005).
  • Uekama K , ImaiT, MaedaT, IrieT, HirayamaF, OtagiriM. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-β-cyclodextrin. J. Pharm. Sci.74(8), 841–845 (1985).
  • Sharma S , LewisS. Taste masking technologies: a review. Int. J. Pharm. Sci.2(2), 6–13 (2010).
  • Kumazawa T , NomuraT, KuriharaK. Liposomes as model for taste cells: receptor sites for bitter substances including N–C=S substances and mechanism of membrane potential changes. Biochemistry27(4), 1239–1244 (1988).
  • Okahata Y , En-NaG, EbatoH. Synthetic chemoreceptive membranes. Sensing bitter or odorous substances on a synthetic lipid multibilayer film by using quartz-crystal microbalances and electric responses. Anal. Chem.62(14), 1431–1438 (1990).
  • Ono N , MiyamotoY, IshiguroTet al. Reduction of bitterness of antihistaminic drugs by complexation with β-cyclodextrins. J. Pharm. Sci. 100(5), 1935–1943 (2011).
  • Funasaki N , UratsujiI, OkunoT, HirotaS, NeyaS. Masking mechanisms of bitter taste of drugs studied with ion selective electrodes. Chem. Pharm. Bull. (Tokyo)54(8), 1155–1161 (2006).
  • Funasaki N , KawaguchiR, IshikawaS, HadaS, NeyaS, KatsuT. Quantitative estimation of the bitter taste intensity of oxyphenonium bromide reduced by cyclodextrins from electromotive force measurements. Anal. Chem.71(9), 1733–1736 (1999).
  • Kataoka M , MiyanagaY, TsujiE, UchidaT. Evaluation of bottled nutritive drinks using a taste sensor. Int. J. Pharm.279(1–2), 107–114 (2004).
  • Miyanaga Y , InoueN, OhnishiA, FujisawaE, YamaguchiM, UchidaT. Quantitative prediction of the bitterness suppression of elemental diets by various flavors using a taste sensor. Pharm. Res.20(12), 1932–1938 (2003).
  • Takagi S , TokoK, WadaK, YamadaH, ToyoshimaK. Detection of suppression of bitterness by sweet substance using a multichannel taste sensor. J. Pharm. Sci.87(5), 552–555 (1998).
  • Toko K . Electronic tongue. Biosens. Bioelectron.13(6), 701–709 (1998).
  • Uchida T , KobayashiY, MiyanagaYet al. A new method for evaluating the bitterness of medicines by semi-continuous measurement of adsorption using a taste sensor. Chem. Pharm. Bull. (Tokyo) 49(10), 1336–1339 (2001).
  • Uchida T , TanigakeA, MiyanagaYet al. Evaluation of the bitterness of antibiotics using a taste sensor. J. Pharm. Pharmacol. 55(11), 1479–1485 (2003).
  • Mady FM , Abou-TalebAE, KhaledKAet al. Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-β-CyD/povidone K30 complexation approach. J. Pharm. Sci. 99(10), 4285–4294 (2010).
  • Mady FM , Abou-TalebAE, KhaledKAet al. Evaluation of carboxymethyl-β-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. Int. J. Pharm. 397(1–2), 1–8 (2010).
  • Szejtli J , SzenteL. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur. J. Pharm. Biopharm.61(3), 115–125 (2005).
  • Woertz K , TissenC, KleinebuddeP, BreitkreutzJ. Rational development of taste masked oral liquids guided by an electronic tongue. Int. J. Pharm.400(1–2), 114–123 (2010).
  • Miyamoto Y , NakaharaM, MotoyamaKet al. Improvement of some physicochemical properties of arundic acid, (R)-(-)-2-propyloctanonic acid, by complexation with hydrophilic cyclodextrins. Int. J. Pharm. 413(1–2), 63–72 (2011).
  • Toda J , MisakiM, KonnoA, WadaT, YasumatsuK. Interaction of cyclodextrins with taste substances. Proc. 4th Int. Flavour Conference1, 19–34 (1985).
  • Shah PP , MashruRC. Formulation and evaluation of taste masked oral reconstitutable suspension of primaquine phosphate. AAPS PharmSciTech9(3), 1025–1030 (2008).
  • Cabral FP , BergamoBB, DantasCA, RiulA, Jr, Giacometti JA. Impedance E-tongue instrument for rapid liquid assessment. Rev. Sci. Instrum.80(2), 026107 (2009).
  • Gupta H , SharmaA, KumarS, RoySK. E-tongue: a tool for taste evaluation. Recent Pat. Drug Deliv. Formul.4(1), 82–89 (2010).
  • Rachid O , SimonsFE, Rawas-QalajiM, SimonsKJ. An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrine. AAPS PharmSciTech11(2), 550–557 (2010).
  • Stojanov M , WimmerR, LarsenKL. Study of the inclusion complexes formed between cetirizine and α-, β-, and γ-cyclodextrin and evaluation on their taste-masking properties. J. Pharm. Sci.100(8), 3177–3185 (2011).
  • Shah PP , MashruRC. Palatable reconstitutable dry suspension of artemether for flexible pediatric dosing using cyclodextrin inclusion complexation. Pharm. Dev. Technol.15(3), 276–285 (2010).
  • Birhade ST , BankarVH, Gaikwad,PD, PawarSP. Preparation and evaluation of cyclodextrin based binary systems for taste masking. J. Pharm. Sci. Drug Res.2(3), 199–203 (2010).
  • Sevukarajan M , ThanujaB, RahulN. Novel inclusion complexes of oseltamivir phosphate-with β-cyclodextrin: physico-chemical characterization. J. Pharm. Sci. Res.2(9), 583–589 (2010).
  • Mahesh A , ShastriN, SadanandamM. Development of taste masked fast disintegrating films of levocetirizine dihydrochloride for oral use. Curr. Drug Deliv.7(1), 21–27 (2010).
  • Patel AR , VaviaPR. Preparation and evaluation of taste masked famotidine formulation using drug/β-cyclodextrin/polymer ternary complexation approach. AAPS PharmSciTech9(2), 544–550 (2008).
  • Uekama K , ArimaH, IrieT, MatsubaraK, KurikiT. Sustained release of buserelin acetate, a luteinizing hormone-releasing hormone agonist, from an injectable oily preparation utilizing ethylated β-cyclodextrin. J. Pharm. Pharmacol.41(12), 874–876 (1989).
  • Matsubara K , IrieT, UekamaK. Spectroscopic characterization of the inclusion complex of a luteinizing hormone-releasing hormone agonist, buserelin acetate, with dimethyl-β-cyclodextrin. Chem. Pharm. Bull. (Tokyo)45(2), 378–383 (1997).
  • Tokihiro K , IrieT, UekamaK. Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution. Chem. Pharm. Bull. (Tokyo)45(3), 525–531 (1997).
  • Tavornvipas S , TajiriS, HirayamaF, ArimaH, UekamaK. Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone. Pharm. Res.21(12), 2369–2376 (2004).
  • Tavornvipas S , HirayamaF, TakedaS, ArimaH, UekamaK. Effects of cyclodextrins on chemically and thermally induced unfolding and aggregation of lysozyme and basic fibroblast growth factor. J. Pharm. Sci.95(12), 2722–2729 (2006).
  • Abe K , IrieT, UekamaK. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-β-cyclodextrin. Chem. Pharm. Bull. (Tokyo)43(12), 2232–2237 (1995).
  • Matsubara K , AndoY, IrieT, UekamaK. Protection afforded by maltosyl-β-cyclodextrin against α-chymotrypsin-catalyzed hydrolysis of a luteinizing hormone-releasing hormone agonist, buserelin acetate. Pharm. Res.14(10), 1401–1405 (1997).
  • Irie T , UekamaK. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev.36(1), 101–123 (1999).
  • Arima H , YunomaeK, HirayamaF, UekamaK. Contribution of P-glycoprotein to the enhancing effects of dimethyl-β-cyclodextrin on oral bioavailability of tacrolimus. J. Pharmacol. Exp. Ther.297(2), 547–555 (2001).
  • Arima H , YunomaeK, MorikawaT, HirayamaF, UekamaK. Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-β-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers. Pharm. Res.21(4), 625–634 (2004).
  • Yunomae K , ArimaH, HirayamaF, UekamaK. Involvement of cholesterol in the inhibitory effect of dimethyl-β-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells. FEBS Lett.536(1–3), 225–231 (2003).
  • Motoyama K , ToyodomeH, OnoderaRet al. Involvement of lipid rafts of rabbit red blood cells in morphological changes induced by methylated β-cyclodextrins. Biol. Pharm. Bull. 32(4), 700–705 (2009).
  • Ohkubo S , NakahataN. Role of lipid rafts in trimeric G protein-mediated signal transduction. Yakugaku Zasshi127(1), 27–40 (2007).
  • Katsuragi Y , KuriharaK. Specific inhibitor for bitter taste. Nature365(6443), 213–214 (1993).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.